Phase I trial of RG 7652 in healthy subjects with elevated LDL-cholesterol levels.
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2017
At a glance
- Drugs RG 7652 (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Biomarker; First in man; Pharmacodynamics
- Sponsors Genentech; Roche
- 22 Mar 2017 Results published in the Clinical Cardiology
- 20 Nov 2013 Results reporting effects of treatment on lipid and inflammatory biomarkers presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History